Cultural Modification of an Evidence Based Healthy Lifestyle Intervention for People Post Stroke Who Identify as Hispanic/Latino
Launched by BAYLOR RESEARCH INSTITUTE · Jul 18, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a specially designed healthy lifestyle program aimed at helping Hispanic and Latino individuals who have had a stroke lose weight. The program has been tailored to be culturally relevant, making it easier for participants to connect with and follow. The goal is to see if this modified approach can effectively support weight loss and promote healthier living among this community.
To participate in the trial, individuals must be between 18 and 85 years old, identify as Hispanic or Latino, and have a body mass index (BMI) of 25 or higher. They should also be at least 12 months post their first stroke and medically cleared to join a weight-loss program. Participants can expect to engage in activities that encourage a healthier lifestyle while receiving support tailored to their cultural background. It’s important to note that individuals with certain health issues, cognitive challenges, or those currently living in a hospital or rehabilitation facility are not eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI ≥25
- • Identify as Hispanic or Latino
- • 18-85 years of age
- • All types of stroke
- • Medically able to participate in a weight-loss program
- • Physical Activity Readiness Questionnaire +
- • ≥12 months post first stroke
- Exclusion Criteria:
- • Contraindications for physical activity
- • Low Cognitive Function
- • Residing in hospital, acute rehab, SNF
- • Not fluent in English or Spanish
- • Pre-existing eating disorder
- • Pregnancy
About Baylor Research Institute
Baylor Research Institute (BRI) is a leading clinical research organization affiliated with Baylor Scott & White Health, dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a focus on translational medicine, BRI conducts a wide range of clinical trials across various therapeutic areas, including cardiovascular, oncology, and neurology. The institute is committed to fostering collaborative partnerships with academic institutions, industry leaders, and healthcare professionals to enhance the development of novel therapies and interventions. Through rigorous scientific methodology and ethical standards, Baylor Research Institute strives to contribute significantly to the advancement of healthcare and to provide patients with access to cutting-edge treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Librada Callender, PhD, MPH
Principal Investigator
Baylor Scott and White Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported